BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16459994)

  • 1. Tuberous sclerosis complex: molecular pathogenesis and animal models.
    Piedimonte LR; Wailes IK; Weiner HL
    Neurosurg Focus; 2006 Jan; 20(1):E4. PubMed ID: 16459994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of tuberous sclerosis complex.
    Scheidenhelm DK; Gutmann DH
    J Child Neurol; 2004 Sep; 19(9):726-33. PubMed ID: 15563020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberous sclerosis as an underlying basis for infantile spasm.
    Yeung RS
    Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
    Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tuberous sclerosis complex genes in tumor development.
    Mak BC; Yeung RS
    Cancer Invest; 2004; 22(4):588-603. PubMed ID: 15565817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis: a syndrome of incomplete tumor suppression.
    McCall T; Chin SS; Salzman KL; Fults DW
    Neurosurg Focus; 2006 Jan; 20(1):E3. PubMed ID: 16459993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.
    Mizuguchi M; Ikeda K; Takashima S
    Acta Neuropathol; 2000 May; 99(5):503-10. PubMed ID: 10805093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.
    Johnson MW; Emelin JK; Park SH; Vinters HV
    Brain Pathol; 1999 Jan; 9(1):45-54. PubMed ID: 9989450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
    Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for population variation in TSC1 and TSC2 gene expression.
    Jentarra GM; Rice SG; Olfers S; Saffen D; Narayanan V
    BMC Med Genet; 2011 Feb; 12():29. PubMed ID: 21345208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
    Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
    van Slegtenhorst M; Nellist M; Nagelkerken B; Cheadle J; Snell R; van den Ouweland A; Reuser A; Sampson J; Halley D; van der Sluijs P
    Hum Mol Genet; 1998 Jun; 7(6):1053-7. PubMed ID: 9580671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V
    Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
    Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
    J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD; Campbell JS; Yeung RS
    J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
    Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
    Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
    Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.